PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
176.45 - 178.59
86.62 - 184.48
124.91M / 173.95M (Avg.)
50.81 | 3.50
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
87.81%
Revenue growth above 1.5x AVGO's 4.40%. David Dodd would confirm if the firm has a unique advantage driving sales higher.
103.57%
Gross profit growth above 1.5x AVGO's 4.90%. David Dodd would confirm if the company's business model is superior in terms of production costs or pricing.
217.76%
EBIT growth above 1.5x AVGO's 18.43%. David Dodd would confirm if core operations or niche positioning yield superior profitability.
217.76%
Operating income growth above 1.5x AVGO's 18.43%. David Dodd would confirm if consistent cost or pricing advantages drive this outperformance.
202.89%
Net income growth above 1.5x AVGO's 60.08%. David Dodd would check if a unique moat or cost structure secures superior bottom-line gains.
201.20%
EPS growth above 1.5x AVGO's 58.62%. David Dodd would review if superior product economics or effective buybacks drive the outperformance.
204.88%
Diluted EPS growth above 1.5x AVGO's 57.14%. David Dodd would see if there's a robust moat protecting these shareholder gains.
0.12%
Share reduction more than 1.5x AVGO's 2.88%. David Dodd would see if the company is taking advantage of undervaluation to retire shares.
0.36%
Diluted share reduction more than 1.5x AVGO's 2.78%. David Dodd would validate if the company is aggressively retiring shares or limiting option exercises.
0.89%
Maintaining or increasing dividends while AVGO cut them. John Neff might see a strong edge in shareholder returns.
118.07%
Positive OCF growth while AVGO is negative. John Neff would see this as a clear operational advantage vs. the competitor.
127.53%
Positive FCF growth while AVGO is negative. John Neff would see a strong competitive edge in net cash generation.
1208.60%
10Y revenue/share CAGR 1.25-1.5x AVGO's 861.53%. Bruce Berkowitz would investigate brand strength or geographical expansion fueling growth.
324.63%
5Y revenue/share CAGR above 1.5x AVGO's 93.24%. David Dodd would look for consistent product or market expansions fueling outperformance.
248.11%
3Y revenue/share CAGR above 1.5x AVGO's 66.58%. David Dodd would confirm if there's an emerging competitive moat driving recent gains.
6130.13%
10Y OCF/share CAGR above 1.5x AVGO's 884.95%. David Dodd would check if a superior product mix or cost edge drives this outperformance.
582.64%
5Y OCF/share CAGR above 1.5x AVGO's 46.62%. David Dodd would confirm if the firm has better cost structures or brand premium boosting mid-term cash flow.
303.63%
3Y OCF/share CAGR above 1.5x AVGO's 13.16%. David Dodd would confirm if the firm is quickly gaining an operational edge over the competitor.
5974.42%
Net income/share CAGR above 1.5x AVGO's 624.61% over 10 years. David Dodd would confirm if brand, IP, or scale secure this persistent advantage.
451.81%
5Y net income/share CAGR above 1.5x AVGO's 162.06%. David Dodd would confirm if the firm’s strategy is more effective in generating mid-term profits.
891.23%
3Y net income/share CAGR above 1.5x AVGO's 25.27%. David Dodd would confirm the company’s short-term strategies outmatch the competitor significantly.
524.07%
Below 50% of AVGO's 1097.33%. Michael Burry would suspect poor capital allocation or persistent net losses eroding long-term equity build-up.
207.00%
5Y equity/share CAGR 1.25-1.5x AVGO's 169.39%. Bruce Berkowitz confirms if reinvested profits or buybacks explain the superior buildup.
96.93%
3Y equity/share CAGR at 50-75% of AVGO's 157.41%. Martin Whitman sees a short-term lag in net worth creation vs. the competitor.
118.44%
Below 50% of AVGO's 1839.26%. Michael Burry might see weaker long-term distribution growth, raising questions about the firm's capital allocation.
7.89%
Below 50% of AVGO's 97.33%. Michael Burry worries the firm returns far less capital to shareholders over 5 years.
0.64%
Below 50% of AVGO's 38.80%. Michael Burry suspects the firm invests elsewhere or can’t match the competitor’s dividend policy.
73.19%
AR growth well above AVGO's 10.69%. Michael Burry fears inflated revenue or higher default risk in the near future.
-6.33%
Both reduce inventory yoy. Martin Whitman suspects a broader move to lean operations or industry slowdown in demand.
11.46%
Positive asset growth while AVGO is shrinking. John Neff sees potential for us to outgrow the competitor if returns are solid.
12.02%
Positive BV/share change while AVGO is negative. John Neff sees a clear edge over a competitor losing equity.
-9.32%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
8.80%
R&D growth drastically higher vs. AVGO's 4.64%. Michael Burry fears near-term margin erosion unless breakthroughs are imminent.
-1.74%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.